Evidence map›Paper›PMID 32307629›Full record

ArticleAngiogenesis2020

Lymphatic MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis.

Lothar C Dieterich, Carlotta Tacconi, Franziska Menzi, Steven T Proulx, Kübra Kapaklikaya, Michito Hamada, Satoru Takahashi, Michael Detmar

Open access · hybridAbstract read
In one paragraph

Article in Angiogenesis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Regulation of VEGFR3 signaling in lymphatic endothelial cells.Frontiers in cell and developmental biology · 2025
    Review
  3. Review
  4. Article
  5. Transcription factors regulating vasculogenesis and angiogenesis.Developmental dynamics : an official publication of the American Association of Anatomists · 2024
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Lothar C DieterichInstitute of Pharmaceutical Sciences, ETH Zurich, 8093, Zurich, Switzerland.ORCID 0000-0001-7908-5710
Carlotta TacconiInstitute of Pharmaceutical Sciences, ETH Zurich, 8093, Zurich, Switzerland.ORCID 0000-0002-6431-7555
Franziska MenziInstitute of Pharmaceutical Sciences, ETH Zurich, 8093, Zurich, Switzerland.
Steven T ProulxInstitute of Pharmaceutical Sciences, ETH Zurich, 8093, Zurich, Switzerland.
Kübra KapaklikayaInstitute of Pharmaceutical Sciences, ETH Zurich, 8093, Zurich, Switzerland.
Michito HamadaDepartment of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, 305-8575, Japan.
Satoru TakahashiDepartment of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, 305-8575, Japan.
Michael DetmarInstitute of Pharmaceutical Sciences, ETH Zurich, 8093, Zurich, Switzerland. michael.detmar@pharma.ethz.ch.
ETH Zurich · CHUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MAFB is a transcription factor involved in the terminal differentiation of several cell types, including macrophages and keratinocytes. MAFB is also expressed in lymphatic endothelial cells (LECs) and is upregulated by VEGF-C/VEGFR-3 signaling. Recent studies have revealed that MAFB regulates several genes involved in lymphatic differentiation and that global Mafb knockout mice show defects in patterning of lymphatic vessels during embryogenesis. However, it has remained unknown whether this effect is LEC-intrinsic and whether MAFB might also be involved in postnatal lymphangiogenesis. We established conditional, lymphatic-specific Mafb knockout mice and found comparable lymphatic patterning defects during embryogenesis as in the global MAFB knockout. Lymphatic MAFB deficiency resulted in increased lymphatic branching in the diaphragm at P7, but had no major effect on lymphatic patterning or function in healthy adult mice. By contrast, tumor-induced lymphangiogenesis was enhanced in mice lacking lymphatic MAFB. Together, these data reveal that LEC-expressed MAFB is involved in lymphatic vascular morphogenesis during embryonic and postnatal development as well as in pathological conditions. Therefore, MAFB could represent a target for therapeutic modulation of lymphangiogenesis.

Indexed as

LymphangiogenesisAnimalsEndothelial CellsHumansLymphatic VesselsMafB Transcription FactorMiceMice, KnockoutVascular Endothelial Growth Factor CVascular Endothelial Growth Factor Receptor-3FLT4 protein, humanMAFB protein, humanMafb protein, mouseMafB Transcription FactorVascular Endothelial Growth Factor Cvascular endothelial growth factor C, mouseVascular Endothelial Growth Factor Receptor-3VEGFC protein, humanBranchingLymphangiogenesisPostnatal developmentTranscription factorVascular morphogenesis

Identifiers

PMID32307629
PMCPMC7311381
OpenAlexW3017296308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.